Spectrum Laboratory Products is recalling 29.1 grams of Fentanyl Citrate USP, an active pharmaceutical ingredient, due to a notice from a supplier regarding potential glass contamination. The affected products were distributed to compounding pharmacies and laboratories in California, Colorado, Maryland, and South Carolina. Using medication contaminated with glass fragments can lead to serious health complications, such as internal irritation or physical injury at the site of administration.
The presence of glass fragments in a pharmaceutical ingredient poses a risk of physical trauma, such as internal cuts, irritation, or blockages, particularly if the contaminated ingredient is compounded into an injectable or liquid medication.
Healthcare consultation and product return.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.